Skip to content
Advertisement

Robert Kramer, president and chief executive officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, Wednesday, May 19, 2021, examining Emergent BioSolutions, a Maryland biotech firm whose Baltimore plant ruined millions of doses of the coronavirus vaccine. (Stefani Reynolds/The New York Times via AP, Pool)
Photo by: Stefani Reynolds
Robert Kramer, president and chief executive officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, Wednesday, May 19, 2021, examining Emergent BioSolutions, a Maryland biotech firm whose Baltimore plant ruined millions of doses of the coronavirus vaccine. (Stefani Reynolds/The New York Times via AP, Pool)

Featured Photo Galleries